CELESTICA INC (CLS) Fundamental Analysis & Valuation

NYSE:CLSCA15101Q2071

Current stock price

396.9 USD
-4.22 (-1.05%)
Last:

This CLS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CLS Profitability Analysis

1.1 Basic Checks

  • CLS had positive earnings in the past year.
  • CLS had a positive operating cash flow in the past year.
  • CLS had positive earnings in each of the past 5 years.
  • In the past 5 years CLS always reported a positive cash flow from operatings.
CLS Yearly Net Income VS EBIT VS OCF VS FCFCLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • CLS's Return On Assets of 11.54% is amongst the best of the industry. CLS outperforms 94.35% of its industry peers.
  • The Return On Equity of CLS (37.56%) is better than 97.58% of its industry peers.
  • CLS has a better Return On Invested Capital (24.36%) than 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CLS is significantly above the industry average of 8.09%.
  • The last Return On Invested Capital (24.36%) for CLS is above the 3 year average (17.88%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROIC 24.36%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
CLS Yearly ROA, ROE, ROICCLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • CLS's Profit Margin of 6.72% is fine compared to the rest of the industry. CLS outperforms 73.39% of its industry peers.
  • In the last couple of years the Profit Margin of CLS has grown nicely.
  • CLS has a better Operating Margin (7.80%) than 72.58% of its industry peers.
  • In the last couple of years the Operating Margin of CLS has grown nicely.
  • With a Gross Margin value of 12.06%, CLS is not doing good in the industry: 75.81% of the companies in the same industry are doing better.
  • CLS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
CLS Yearly Profit, Operating, Gross MarginsCLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

8

2. CLS Health Analysis

2.1 Basic Checks

  • CLS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for CLS has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CLS has less shares outstanding
  • Compared to 1 year ago, CLS has an improved debt to assets ratio.
CLS Yearly Shares OutstandingCLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
CLS Yearly Total Debt VS Total AssetsCLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • CLS has an Altman-Z score of 8.07. This indicates that CLS is financially healthy and has little risk of bankruptcy at the moment.
  • CLS has a better Altman-Z score (8.07) than 80.65% of its industry peers.
  • CLS has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
  • CLS has a Debt to FCF ratio of 1.69. This is amongst the best in the industry. CLS outperforms 83.06% of its industry peers.
  • A Debt/Equity ratio of 0.34 indicates that CLS is not too dependend on debt financing.
  • CLS has a worse Debt to Equity ratio (0.34) than 62.90% of its industry peers.
  • Although CLS's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Altman-Z 8.07
ROIC/WACC2.7
WACC9.02%
CLS Yearly LT Debt VS Equity VS FCFCLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • CLS has a Current Ratio of 1.44. This is a normal value and indicates that CLS is financially healthy and should not expect problems in meeting its short term obligations.
  • CLS has a worse Current ratio (1.44) than 77.42% of its industry peers.
  • A Quick Ratio of 0.88 indicates that CLS may have some problems paying its short term obligations.
  • CLS's Quick ratio of 0.88 is on the low side compared to the rest of the industry. CLS is outperformed by 86.29% of its industry peers.
  • CLS does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.88
CLS Yearly Current Assets VS Current LiabilitesCLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

9

3. CLS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.59% over the past year.
  • CLS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.67% yearly.
  • Looking at the last year, CLS shows a very strong growth in Revenue. The Revenue has grown by 28.46%.
  • The Revenue has been growing by 16.61% on average over the past years. This is quite good.
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%

3.2 Future

  • CLS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.90% yearly.
  • Based on estimates for the next years, CLS will show a very strong growth in Revenue. The Revenue will grow by 36.47% on average per year.
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue Next Year42.22%
Revenue Next 2Y41.08%
Revenue Next 3Y36.47%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLS Yearly Revenue VS EstimatesCLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B
CLS Yearly EPS VS EstimatesCLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

4

4. CLS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 65.50 indicates a quite expensive valuation of CLS.
  • The rest of the industry has a similar Price/Earnings ratio as CLS.
  • When comparing the Price/Earnings ratio of CLS to the average of the S&P500 Index (27.95), we can say CLS is valued expensively.
  • The Price/Forward Earnings ratio is 44.09, which means the current valuation is very expensive for CLS.
  • CLS's Price/Forward Earnings ratio is in line with the industry average.
  • CLS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 38.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 65.5
Fwd PE 44.09
CLS Price Earnings VS Forward Price EarningsCLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • CLS's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CLS.
Industry RankSector Rank
P/FCF 99.57
EV/EBITDA 40.55
CLS Per share dataCLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • CLS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CLS has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLS's earnings are expected to grow with 40.90% in the coming years.
PEG (NY)1.35
PEG (5Y)1.5
EPS Next 2Y46.28%
EPS Next 3Y40.9%

0

5. CLS Dividend Analysis

5.1 Amount

  • CLS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CLS Fundamentals: All Metrics, Ratios and Statistics

CELESTICA INC

NYSE:CLS (4/21/2026, 11:01:08 AM)

396.9

-4.22 (-1.05%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-28
Earnings (Next)04-27
Inst Owners72.32%
Inst Owner Change-0.07%
Ins Owners0.59%
Ins Owner Change50.49%
Market Cap45.63B
Revenue(TTM)12.39B
Net Income(TTM)832.50M
Analysts82.35
Price Target267.89 (-32.5%)
Short Float %2.77%
Short Ratio1.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.27%
Min EPS beat(2)5.95%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)7.73%
Min EPS beat(4)5.95%
Max EPS beat(4)11.71%
EPS beat(8)8
Avg EPS beat(8)9.02%
EPS beat(12)12
Avg EPS beat(12)8.99%
EPS beat(16)16
Avg EPS beat(16)8.6%
Revenue beat(2)2
Avg Revenue beat(2)4.43%
Min Revenue beat(2)3.86%
Max Revenue beat(2)5%
Revenue beat(4)4
Avg Revenue beat(4)4.69%
Min Revenue beat(4)2.5%
Max Revenue beat(4)7.4%
Revenue beat(8)7
Avg Revenue beat(8)3.75%
Revenue beat(12)11
Avg Revenue beat(12)3.24%
Revenue beat(16)15
Avg Revenue beat(16)3.66%
PT rev (1m)-0.87%
PT rev (3m)6.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.01%
EPS NY rev (1m)0%
EPS NY rev (3m)7.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.4%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)7.3%
Valuation
Industry RankSector Rank
PE 65.5
Fwd PE 44.09
P/S 3.68
P/FCF 99.57
P/OCF 69.19
P/B 20.59
P/tB 28.22
EV/EBITDA 40.55
EPS(TTM)6.06
EY1.53%
EPS(NY)9
Fwd EY2.27%
FCF(TTM)3.99
FCFY1%
OCF(TTM)5.74
OCFY1.45%
SpS107.78
BVpS19.28
TBVpS14.06
PEG (NY)1.35
PEG (5Y)1.5
Graham Number51.2684 (-87.08%)
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 37.56%
ROCE 29.51%
ROIC 24.36%
ROICexc 29.78%
ROICexgc 38.37%
OM 7.8%
PM (TTM) 6.72%
GM 12.06%
FCFM 3.7%
ROA(3y)7.61%
ROA(5y)5.53%
ROE(3y)24.65%
ROE(5y)17.94%
ROIC(3y)17.88%
ROIC(5y)13.64%
ROICexc(3y)21.34%
ROICexc(5y)16.25%
ROICexgc(3y)28.33%
ROICexgc(5y)22.11%
ROCE(3y)21.66%
ROCE(5y)16.53%
ROICexgc growth 3Y42.82%
ROICexgc growth 5Y38.52%
ROICexc growth 3Y48.19%
ROICexc growth 5Y40.13%
OM growth 3Y32.38%
OM growth 5Y32.85%
PM growth 3Y49.6%
PM growth 5Y44.64%
GM growth 3Y11.17%
GM growth 5Y11.4%
F-Score7
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.69
Debt/EBITDA 0.66
Cap/Depr 114.51%
Cap/Sales 1.62%
Interest Coverage 17.86
Cash Conversion 57.76%
Profit Quality 55.05%
Current Ratio 1.44
Quick Ratio 0.88
Altman-Z 8.07
F-Score7
WACC9.02%
ROIC/WACC2.7
Cap/Depr(3y)107.56%
Cap/Depr(5y)87.85%
Cap/Sales(3y)1.66%
Cap/Sales(5y)1.48%
Profit Quality(3y)69.38%
Profit Quality(5y)101.2%
High Growth Momentum
Growth
EPS 1Y (TTM)54.59%
EPS 3Y46.94%
EPS 5Y43.67%
EPS Q2Q%70.27%
EPS Next Y48.55%
EPS Next 2Y46.28%
EPS Next 3Y40.9%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y19.56%
Revenue growth 5Y16.61%
Sales Q2Q%43.57%
Revenue Next Year42.22%
Revenue Next 2Y41.08%
Revenue Next 3Y36.47%
Revenue Next 5YN/A
EBIT growth 1Y69.46%
EBIT growth 3Y58.27%
EBIT growth 5Y54.91%
EBIT Next Year74.41%
EBIT Next 3Y58.82%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3Y34.37%
FCF growth 5Y19.66%
OCF growth 1Y39.16%
OCF growth 3Y30.33%
OCF growth 5Y22.45%

CELESTICA INC / CLS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CELESTICA INC?

ChartMill assigns a fundamental rating of 7 / 10 to CLS.


What is the valuation status of CELESTICA INC (CLS) stock?

ChartMill assigns a valuation rating of 4 / 10 to CELESTICA INC (CLS). This can be considered as Fairly Valued.


Can you provide the profitability details for CELESTICA INC?

CELESTICA INC (CLS) has a profitability rating of 8 / 10.


What is the expected EPS growth for CELESTICA INC (CLS) stock?

The Earnings per Share (EPS) of CELESTICA INC (CLS) is expected to grow by 48.55% in the next year.